Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CAPU RISE: Cannabis Effects on Stress in Healthy Polysubstance Users
NCT05261321Phase 1Active, not recruiting
- Sponsor
- University of British Columbia
- Start
- Oct 2022
- Primary completion
- Mar 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, double-blind trial of cannabis oil (3 arms), sponsored by University of British Columbia. Primary endpoints: Change in stress response across conditions at 5 weeks, Change in incidence of adverse events of cannabinoids across conditions at 5 weeks and 2 more. Started Oct 2022; status: active, not recruiting.
02
Drugs
cannabis oil
Beyond the preview
Go deeper on NCT05261321.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05261321.